Bionic Sight

A new treatment for advanced stage blindness combining gene therapy with a neural coding device

New York, United States · Founded 2012

Headquarters
New York, New York
Employees
1–10
Founded
2012
Business Model
B2B

About

Bionic Sight, Inc. is a biotech company developing next-generation optogenetic gene therapies to treat retinal and neurodegenerative diseases. Founded by Dr. Sheila Nirenberg, a professor at the Weill Medical College of Cornell University and MacArthur Fellow, the company's technology builds on her research into deciphering the retina's neural code and using it to restore visual function. The company's lead program, BS01, is an optogenetic treatment with a novel mechanism that combines gene therapy with a neural coding device. Bionic Sight's therapy has received RMAT (Regenerative Medicine Advanced Therapy) designation from the FDA, and targets conditions including retinitis pigmentosa, geographic atrophy, Stargardt's disease, and choroideremia. Clinical trial NCT04278131 demonstrated that blind patients were able to detect light and motion following treatment.

Summary

Bionic Sight is a Biotech company based in New York, United States, founded in 2012.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Bionic Sight on Indexed.vc
<a href="https://indexed.vc/companies/bionic-sight"><img src="https://indexed.vc/api/badge/company/bionic-sight" alt="Bionic Sight on Indexed.vc" width="260" height="76" /></a>